Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 267-500-0 | CAS number: 67874-72-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Genemutation in bacterial cells, Ames test (OECD TG 471): negative
Genemutation in mammalian cells, the MLA (OECD TG 476): negative
Chromosomal aberrations in mammalian cells, (OECD TG 473): negative
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Bacterial reverse mutation assay (e.g. Ames test)
The mutagenic activity of the substance was evaluated in accordance with OECD 471 and according to GLP principles. The test was performed in two independentplate incorporationexperiments, both in the absence and presence of S9-mix. The dose levels were selected based on the dose range finding experiment. Adequate negative and positive controls were included. The substance did not induce a significant dose-related increase in the number of revertant colonies in each of the five S. typhimurium tester strains (TA1535, TA1537, TA98, TA100) and E. Coli WP2 uvrA), both in the absence and presence of S9-metabolic activation. Based on the results of this study it is concluded that the substance is not mutagenic with and without metabolic activation
Additional information: A recent Ames test (2015) is available in the database of Research Institute for Fragrance Materials (RIFM). In an OECD TG 471 study no mutagenicity in bacterial cells was seen.
Mammalian cell gene mutation assay
An in vitro mammalian gene mutation test was performed according to OECD guideline 476 and in compliance with GLP. Mouse lymphoma L5178Y cells were exposed to 2.0, 5.0, 8.0, 11, 14, and 17 µg/mL without metabolic activation and 40, 55, 70, 85, 100, and 115 µg/mL with metabolic activation for 4 hours (expression time 20 and 44 hours). Furthermore, a confirmatory experiment was performed with 5.0, 8.0, 11, 14, 17, 20, 23, and 26 µg/mL test substance for 24-hours without metabolic activation. The mutant frequencies and relative total growth were determined. Positive and solvent controls induced the appropriate response. Under the conditions of the test the results of the definitive and confirmatory mutation assays were considered negative.
In vitro mammalian chromosome aberration test
An in vitro chromosome aberration test was performed according to OECD guideline 473 and in compliance with GLP. Chinese hamster Ovary (CHO) cells were exposed to 10, 20, 30, 35, 40, and 45 μg/mL (without S-9) and 25, 50, 60, 70, 80, and 90 μg/mL (with S-9) in the definitive test. Doses were selected based on a dose range finder. Furthermore a confirmatory test was performed with 10, 20, 25, 30, and 35 μg/mL test substance without S-9. Cells were exposed for 3 hours (+15 hours recovery) in the definitive test and exposed for 18 hours in the confirmatory test. Positive and solvent controls induced the appropriate response. The results from the Definitive and Confirmatory Chromosome Aberration Assays indicate that the test article did not induce a statistically significant increase in the percentage of cells with aberrations both with and without metabolic activation when compared to the solvent controls. Therefore, under the conditions of this test and according to the criteria set for evaluating the test results, the test substance was negative (not clastogenic) in the CHO Chromosome Aberration Assay both with and without metabolic activation.
Justification for classification or non-classification
Based on the results of the Ames test, mouse lymphoma assay, and chromomal aberration test, the substance does not have to be classified for genetic toxicity in accordance with Regulation (EC) No. 1272/2008 and its updates.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.